DS
Design Ther
DSGN·NASDAQCarlsbad CAFounded 201680 employees
Small CapbiotechPublicRare Disease
Platform: DT216 Fabry Gene
Market Cap
$0.6B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (DSGN)
Loading DSGN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DSG-6263 | DSG-6263 | Phase 1/2 | 2 | MDM2 | Breast Ca | ||
| Ivoratamab | DSG-4887 | Phase 2/3 | 2 | Tau | ADPKD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)